These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9681239)

  • 1. Persistent bone marrow failure with dysplastic features following pentostatin therapy for hairy cell leukaemia.
    Psiachou-Leonard E; Bain BJ
    Clin Lab Haematol; 1998 Jun; 20(3):195-7. PubMed ID: 9681239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trials of pentostatin (Nipent) in hairy cell leukemia.
    Kraut EH
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):27-31. PubMed ID: 10877048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelioid microgranulomas after Pentostatin therapy in hairy cell leukaemia.
    Sironi M; Lodato A; Sciariada L; Spinelli M
    Histopathology; 2002 May; 40(5):483-5. PubMed ID: 12010371
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment of aplastic variant of hairy-cell leukaemia with deoxycoformycin.
    Ng JP; Nolan B; Chan-Lam D; Coup AJ; McKenna D
    Hematology; 2002 Aug; 7(4):259-62. PubMed ID: 14972788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentostatin (Nipent) in the treatment of chronic lymphocyte leukemia and hairy cell leukemia.
    Dillman RO
    Expert Rev Anticancer Ther; 2004 Feb; 4(1):27-36. PubMed ID: 14748654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentostatin (2'-deoxycoformycin) in the treatment of cutaneous T-cell lymphoma.
    Greiner D; Olsen EA; Petroni G
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):950-5. PubMed ID: 9204061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentostatin in the treatment of hairy-cell leukemia.
    Grever MR; Doan CA; Kraut EH
    Best Pract Res Clin Haematol; 2003 Mar; 16(1):91-9. PubMed ID: 12670468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentostatin induces durable remissions in hairy cell leukemia.
    Cassileth PA; Cheuvart B; Spiers AS; Harrington DP; Cummings FJ; Neiman RS; Bennett JM; O'Connell MJ
    J Clin Oncol; 1991 Feb; 9(2):243-6. PubMed ID: 1988572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin.
    Flinn IW; Kopecky KJ; Foucar MK; Head D; Bennett JM; Hutchison R; Corbett W; Cassileth P; Habermann T; Golomb H; Rai K; Eisenhauer E; Appelbaum F; Cheson B; Grever MR
    Blood; 2000 Nov; 96(9):2981-6. PubMed ID: 11049974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer.
    Ho AD; Suciu S; Stryckmans P; De Cataldo F; Willemze R; Thaler J; Peetermans M; Döhner H; Solbu G; Dardenne M; Zittoun R
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):52-7. PubMed ID: 10877053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response duration and recovery of CD4+ lymphocytes following deoxycoformycin in interferon-alpha-resistant hairy cell leukemia: 7-year follow-up.
    Seymour JF; Talpaz M; Kurzrock R
    Leukemia; 1997 Jan; 11(1):42-7. PubMed ID: 9001417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients.
    Maloisel F; Benboubker L; Gardembas M; Coiffier B; Divine M; Sebban C; Blanc M; Abgrall JF; Lederlin P; Harousseau JL; Blaise AM; Grosbois B; Morice P; Ghandour C; Castaigne S
    Leukemia; 2003 Jan; 17(1):45-51. PubMed ID: 12529659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term outcome of patients with hairy cell leukemia treated with pentostatin.
    Ribeiro P; Bouaffia F; Peaud PY; Blanc M; Salles B; Salles G; Coiffier B
    Cancer; 1999 Jan; 85(1):65-71. PubMed ID: 9921975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
    Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
    Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of essential thrombocythemia in a patient treated with interferon alfa and pentostatin for hairy cell leukemia.
    Lichtman SM; Wasil T; Ahmad M; Brody J
    Leuk Lymphoma; 1998 Jan; 28(3-4):423-7. PubMed ID: 9517515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of apoptosis in vivo and in vitro in hairy cell leukemia treated by deoxycoformycin.
    Ogawa K; Shichishima T; Nakamura N; Maruyama Y
    Tohoku J Exp Med; 2000 Sep; 192(1):87-98. PubMed ID: 11128872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelodysplasia terminating in acute myeloid leukemia in a hairy cell leukemia patient treated with 2-deoxycoformycin.
    Todd SA; Morris TC; Alexander HD
    Leuk Lymphoma; 2002 Jun; 43(6):1343-4. PubMed ID: 12153007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of patients with hairy cell leukaemia treated with pentostatin: lymphocyte subpopulations and residual bone marrow infiltration.
    Thaler J; Grünewald K; Gattringer C; Ho AD; Weyrer K; Dietze O; Stauder R; Fluckinger T; Lang A; Huber H
    Br J Haematol; 1993 May; 84(1):75-82. PubMed ID: 8338781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia.
    O'Dwyer PJ; Cheson BD; Leyland-Jones B; King SA; Hoth DF
    Oncology (Williston Park); 1988 Jun; 2(6):17-23, 26-7. PubMed ID: 3079330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hairy cell leukemia successfully treated with 2'-deoxycoformycin following refractoriness to splenectomy and alpha-interferon therapy].
    Shibata T; Hotta T
    Rinsho Ketsueki; 1992 Feb; 33(2):216-20. PubMed ID: 1635172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.